FR2641081A1 - - Google Patents

Download PDF

Info

Publication number
FR2641081A1
FR2641081A1 FR8817097A FR8817097A FR2641081A1 FR 2641081 A1 FR2641081 A1 FR 2641081A1 FR 8817097 A FR8817097 A FR 8817097A FR 8817097 A FR8817097 A FR 8817097A FR 2641081 A1 FR2641081 A1 FR 2641081A1
Authority
FR
France
Prior art keywords
antibodies
peptide
solid phase
peptides
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8817097A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medgenix Group SA
Original Assignee
Medgenix Group SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medgenix Group SA filed Critical Medgenix Group SA
Priority to FR8817097A priority Critical patent/FR2641081A1/fr
Priority to CA002006118A priority patent/CA2006118A1/fr
Priority to EP89403601A priority patent/EP0375555A1/fr
Priority to JP1334656A priority patent/JPH02291297A/ja
Publication of FR2641081A1 publication Critical patent/FR2641081A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR8817097A 1988-12-23 1988-12-23 Withdrawn FR2641081A1 (enExample)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8817097A FR2641081A1 (enExample) 1988-12-23 1988-12-23
CA002006118A CA2006118A1 (fr) 1988-12-23 1989-12-20 Peptides, anticorps diriges contre ces peptides, et procedes de detection et de dosage de papillomavirus hpv16
EP89403601A EP0375555A1 (fr) 1988-12-23 1989-12-21 Peptides, anticorps dirigés contre ces peptides, et procédés de détection et de dosage de papillomavirus HPV16
JP1334656A JPH02291297A (ja) 1988-12-23 1989-12-22 ペプチド類、これらのペプチド類に向けられた抗体及びｈｐｖ１６パピロマウイルスの検出及びアッセイ方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8817097A FR2641081A1 (enExample) 1988-12-23 1988-12-23

Publications (1)

Publication Number Publication Date
FR2641081A1 true FR2641081A1 (enExample) 1990-06-29

Family

ID=9373358

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8817097A Withdrawn FR2641081A1 (enExample) 1988-12-23 1988-12-23

Country Status (4)

Country Link
EP (1) EP0375555A1 (enExample)
JP (1) JPH02291297A (enExample)
CA (1) CA2006118A1 (enExample)
FR (1) FR2641081A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907721A1 (de) * 1989-03-10 1990-09-20 Behringwerke Ag Immunogene regionen auf dem e7-protein des humanen papillomvierus typ 16
IE910909A1 (en) * 1990-03-20 1991-09-25 Behringwerke Ag Seroreactive epitopes of human Papillomavirus (HPV) 16¹proteins
SE9001705D0 (sv) * 1990-05-11 1990-05-11 Medscand Ab Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
US5932412A (en) * 1990-05-11 1999-08-03 Euro-Diagnostica Ab Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes
US6183745B1 (en) 1990-12-12 2001-02-06 The University Of Queensland Subunit papilloma virus vaccine and peptides for use therein
KR100252371B1 (ko) * 1990-12-12 2000-05-01 포터 더글라스 서브유니트 파필로마비루스 백신 및 그들에 사용하기 위한 펩티드
FR2670797A1 (fr) * 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
PT523391E (pt) * 1991-07-13 2003-08-29 Dade Behring Marburg Gmbh Utilizacao dos peptidos derivados dos genes hpv-16 e6 e e7 para fins de diagnostico
IL105554A (en) 1992-05-05 1999-08-17 Univ Leiden Peptides of human papillomavirus for use in preparations elicit a human T cell response
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines
AUPM358894A0 (en) * 1994-01-31 1994-02-24 Csl Limited Modified papilloma virus l2 protein and vlps formed therefrom
GB9420146D0 (en) * 1994-10-06 1994-11-23 Cancer Res Campaign Tech Papillomavirus vaccine
DE19925199A1 (de) 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
DE19925235A1 (de) 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
FR2794370B1 (fr) * 1999-06-03 2003-10-17 Biovector Therapeutics Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
FR2794371B1 (fr) * 1999-10-07 2004-06-18 Biovector Therapeutics Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination
KR101981532B1 (ko) * 2014-06-12 2019-09-02 라 파마슈티컬스 인코포레이티드 보체 활성의 조절
CN113533733A (zh) * 2021-07-14 2021-10-22 上海交通大学 用于检测人血中aep蛋白水平的化学发光免疫检测试剂盒

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001375A1 (fr) * 1985-08-26 1987-03-12 Institut Pasteur Polypeptides et anticorps caracteristiques du papillomavirus, methodes de diagnostic et vaccins les utilisant
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
EP0257754A2 (en) * 1986-07-10 1988-03-02 The Board Of Trustees Of The Leland Stanford Junior University Synthetic peptides of human Papilloma virus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001375A1 (fr) * 1985-08-26 1987-03-12 Institut Pasteur Polypeptides et anticorps caracteristiques du papillomavirus, methodes de diagnostic et vaccins les utilisant
EP0257754A2 (en) * 1986-07-10 1988-03-02 The Board Of Trustees Of The Leland Stanford Junior University Synthetic peptides of human Papilloma virus
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS OF JAPAN, vol. 109, no. 3, 18 juillet 1988, page 180, résumé no. 18185t, Columbus, Ohio, US; & DE-A-3 625 257 (BEHRINGWERKE AG) 04-02-1988 *
CHEMICAL ABSTRACTS, vol. 108, no. 1, 4 janvier 1988, page 151, résumé no. 1513e, Columbus, Ohio, US; J.M. FIRZLAFF et al.: "Polyclonal antibodies to human papillomavirus type-6b and type-16 bacterially derived fusion proteins", & CANCER CELLS 1987, 5 (PAPILLOMAVIRUSES) 105-13 *
CHEMICAL ABSTRACTS, vol. 108, no. 13, 28 mars 1988, page 345, résumé no. 109354t, Columbus, Ohio, US; L. BANKS et al.: "Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization", & J. GEN. VIROL. 1987, 68(12) *
CHEMICAL ABSTRACTS, vol. 109, no. 11, 12 september 1988, page 491, résumé no. 90524v, Columbus, Ohio, US; J.M. FIRZLAFF et al.: "Detection of human papillomavirus capsid antigens in various aquamous epithelial lesions using antibodies directed against the L1 and L2 open reading frames", & VIROLOGY 1988, 164(2), 467-77 *

Also Published As

Publication number Publication date
JPH02291297A (ja) 1990-12-03
EP0375555A1 (fr) 1990-06-27
CA2006118A1 (fr) 1990-06-23

Similar Documents

Publication Publication Date Title
FR2641081A1 (enExample)
Grauballe et al. Optimized enzyme‐linked immunosorbent assay for detection of human and bovine rotavirus in stools: Comparison with electron‐microscopy, immunoelectro‐osmophoresis, and fluorescent antibody techniques
Dubois-Dalcq et al. Protein A-peroxidase: a valluable tool for the localization of antigens.
Roden et al. Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor
Baird Serological evidence for the association of papillomavirus and cervical neoplasia
EP0277437B1 (fr) Agent viral de l'hépatite NANB, antigène et réactif immunologique
Anil et al. Monoclonal antibodies developed for sensitive detection and comparison of white spot syndrome virus isolates in India
FI97426C (fi) Menetelmä ihmisen papilloomaviruksen (HPV) toteamiseksi diagnostista käyttöä varten
JPS63183600A (ja) ヒト乳頭腫ウイルスの診断用ペプチド
Cowsert et al. Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies
Heino et al. Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma
JPH06501542A (ja) 診断用免疫検定法に有用なヒト乳頭腫ウイルス１，５，６，８，１１，１６，１８，３１，３３および５６の合成ペプチド類
JPS60252498A (ja) ヒトサイトメガロウィルス特異的ＩｇＭの検出方法及びそのための手段
FR2586428A1 (fr) Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro, a la prevention et/ou la lutte contre des infections a papillomavirus
JP2001505778A (ja) ＨＩＶ感染の初期の検出のための未変性の（ｎｏｎ―ｄｅｎｔｕｒｅｄ）ＨＩＶ抗原を使用する新規のＥＩＡ試験
EP0569309B1 (fr) Polypeptides de synthèse appartenant au virus de l'hépatite C (VHC) et utilisables notamment pour détecter ce dernier
KR101647159B1 (ko) 조성물, 방법 및 키트
WO2012100598A1 (zh) 类风湿关节炎早期特异性抗原过氧化物还原酶iv
Avsic-Zupanc et al. Evidence for Hantavirus disease in Slovenia, Yugoslavia.
EP2470907A1 (fr) Proteines utilisees pour le diagnostic d'une borreliose de lyme
EP0801744B1 (fr) Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif
EP0993616B1 (fr) Reactif de detection et suivi des infections virales
FR2606515A1 (fr) Procede pour l'isolement d'un nouvel agent viral et de l'antigene qui lui est associe, agent viral et antigene obtenus par ce procede et procede de detection dudit antigene a l'aide d'un reactif immunologique approprie
Snyder et al. Binding by immunoglobulin to the HPV-16-derived proteins L1 and E4 in cervical secretions of women with HPV-related cervical disease
JPH11509424A (ja) 合成ｈｐｖ１１ウイルス様粒子

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse